CervoMed presents neflamapimod DLB trial data at AAIC 2026

Go back to CervoMed presents neflamapimod DLB trial data at AAIC 2026
(NASDAQ: CRVO) Delayed: 2.43 -0.12 (4.71%)
Previous Close $2.55    52 Week High
Open $2.53    52 Week Low
Day High $2.58    P/E N/A 
Day Low $2.43    EPS
Volume 180,759